Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven-year single-centre experience

BACKGROUND: Massive bleeding is one of the commonest salvageable causes of death. The search for an ideal haemostatic agent during massive bleeding is still ongoing. One of the novel haemostatic medications is recombinant activated factor VII (rFVIIa). To date, the usage of rFVIIa during massive hae...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Hematol
Auteurs principaux: Shah, Nurfatin Mohd, Chong, Soon Eu, Yusoff, Syahirah Mohamed, Mazlan, Mohd Zulfakar, Johan, Khairul Bariah, Azman, Nizuwan, Lim, Jo Anne, Mohamad, Siti Mardhiana, Noordin, Siti Salmah, Ghaffar, Zainab Abdul, Hassan, Mohd Hasyizan, Zabidi, Muhammad Azrul, Rahim, Nur Arzuar Abdul
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6251212/
https://ncbi.nlm.nih.gov/pubmed/30498571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12878-018-0126-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires